ROHSAD LIMITED

Executive Summary

Rohsad Limited is a newly formed micro-entity with a clean compliance record and positive net current assets, suggesting low immediate financial risk. However, limited operating history and sole director control warrant further due diligence on operational viability and governance practices. Overall, the company presents as a low-risk investment candidate at this early stage, contingent upon satisfactory future performance verification.

ROHSAD LIMITED - Analysis Report

Company Number: 14812873

Analysis Date: 2025-07-29 14:27 UTC

1. Risk Rating: LOW
   The company, Rohsad Limited, is a recently incorporated private limited company operating in a specialist medical practice sector. It has filed timely accounts and confirmation statements, demonstrating regulatory compliance. Its micro-entity financials show positive net current assets and shareholder funds, indicating an initial healthy balance sheet with no apparent solvency or liquidity concerns at this early stage.

2. Key Concerns:

• Limited Operating History: Incorporated in April 2023, the company has less than one full year of trading history, making it difficult to assess operational sustainability or revenue generation trends.
• Single Director and Shareholder Control: Dr Girendra Sadera holds full ownership and control, which could present governance risks if no additional oversight mechanisms are in place.
• Lack of Audited Financials: As a micro-entity, accounts are unaudited which limits the assurance of financial accuracy and completeness.

3. Positive Indicators:

• Compliance: All statutory filings, including annual accounts and confirmation statements, are up to date and not overdue.
• Positive Working Capital: Current assets exceed current liabilities by £13,684, indicating the company can meet short-term obligations as of the latest financial year-end.
• Clear Ownership Structure: PSC information is transparent with a single controlling individual, which simplifies accountability and decision-making.

4. Due Diligence Notes:

• Review detailed operational plans and revenue forecasts given the short trading history to assess growth prospects and sustainability.
• Verify cash flow statements or bank statements to confirm liquidity beyond balance sheet snapshots.
• Investigate if there are any off-balance sheet liabilities or contingent risks not reflected in the micro-entity accounts.
• Assess director credentials and any potential conflicts of interest given sole control by one individual.
• Confirm if there are any pending legal or regulatory issues, especially given the specialist medical sector’s regulatory environment.